4//SEC Filing
Onaitis Matthew 4
Accession 0001209191-17-053302
CIK 0001610618other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:45 PM ET
Size
7.5 KB
Accession
0001209191-17-053302
Insider Transaction Report
Form 4
Onaitis Matthew
Gnrl Counsel, CFO & Secretary
Transactions
- Award
Common Stock
2017-09-18+15,000→ 15,872 total - Exercise/Conversion
Restricted Stock Unit
2017-09-18+25,000→ 25,000 total→ Common Stock (25,000 underlying)
Footnotes (4)
- [F1]1/3rd of the total number of shares subject to the restricted stock unit shall vest on each December 31 of 2018, 2019 and 2020.
- [F2]Includes 872 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 19, 2017.
- [F3]Restricted stock units convert into common stock on a one-for-one basis.
- [F4]A portion of the shares vest upon the achievement of various clinical and corporate milestones.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001362822
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 4:45 PM ET
- Size
- 7.5 KB